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Abstract
Analysis of the paired i.e. matching TCR a- and b-chain rearrangements of single human T cells is required for a precise
investigation of clonal diversity, tissue distribution and specificity of protective and pathologic T-cell mediated immune
responses. Here we describe a multiplex RT-PCR based technology, which for the first time allows for an unbiased analysis of
the complete sequences of both a- and b-chains of TCR from single T cells. We validated our technology by the analysis of
the pathologic T-cell infiltrates from tissue lesions of two T-cell mediated autoimmune diseases, psoriasis vulgaris (PV) and
multiple sclerosis (MS). In both disorders we could detect various T cell clones as defined by multiple T cells with identical a-
and b-chain rearrangements distributed across the tissue lesions. In PV, single cell TCR analysis of lesional T cells identified
clonal CD8+ T cell expansions that predominated in the epidermis of psoriatic plaques. An MS brain lesion contained two
dominant CD8+ T-cell clones that extended over the white and grey matter and meninges. In both diseases several clonally
expanded T cells carried dual TCRs composed of one Vb and two different Va-chain rearrangements. These results show
that our technology is an efficient instrument to analyse ab-T cell responses with single cell resolution in man. It should
facilitate essential new insights into the mechanisms of protective and pathologic immunity in many human T-cell mediated
conditions and allow for resurrecting functional TCRs from any ab-T cell of choice that can be used for investigating their
specificity.
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Introduction
T cells are essential for protective immunity against infections
and malignant tumors. Furthermore, they may confer patho-
genic immune responses in autoimmune disorders such as
multiple sclerosis, psoriasis vulgaris, rheumatoid arthritis, type I
diabetes, inflammatory bowel disease and others. Advances in
understanding the mechanisms of protective and pathogenic T-
cell responses in man have been hampered by the fact that
often neither the relevant T cell populations nor their antigen
specificity could be defined. T-cell receptor (TCR) analysis has
been used to address these issues but provided only incomplete
insights. Most techniques to analyze the human TCR repertoire
were limited to TCR b-chains, i.e., they revealed only ‘‘half the
truth’’, while an unbiased characterization of complete TCR
molecules could not yet be achieved [1]. Monoclonal TCR
antibodies are only available for a limited number of TRBV
regions. RT-PCR-amplification, spectratyping, and random
cloning of TCR b-chain transcripts provided only estimates of
the heterogeneity of T-cell populations. A technique to analyse
a-chains from single T cells obtained by laser-microdissection
was limited to clonally expanded T cell populations that could
be identified by anti-TCR Vb-chain antibodies [2]. An unbiased
characterization of the paired, i.e. complementary TCR a- and
TCR b-chain from single human T cells, which would be
required to define the specificity of T-cell responses [3],
however, failed hitherto due to the huge diversity of genetic
elements from which functional TCR ab transcripts are
generated [4]. As a consequence, the pathomechanism of many
human T-cell mediated conditions have remained elusive.
To overcome this obstacle in the characterization of T-cell
mediated immunity we developed a multiplex RT-PCR-based
protocol to determine paired ab-TCR rearrangements from any
single T cell of choice without prior knowledge of their particular
TRAV or TRBV usage. We assessed its capacity to characterize
pathologic T-cell infiltrates in two T cell-mediated autoimmune
disorders, psoriasis vulgaris (PV) and multiple sclerosis (MS).
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PV is a chronic, recurrent inflammatory skin disease resulting
from a T-cell mediated immune response in the skin [5].
Former analyses of TCR b-chain repertoires of lesional psoriatic
T-cell infiltrates by random amplification, cloning and sequenc-
ing of TCR b-chain cDNA from lesional biopsies had suggested
select oligoclonal T-cell expansions [6,7,8,9], but the precise
clonality, subtype and tissue distribution of the pathogenic T
cells has remained unknown. MS is believed to be an
autoimmune disease where clonally expanded lymphocytes can
be detected in different regions of the brain [10,11] and CD8+
T cells are thought to mediate an inflammatory attack on the
central nervous system [12,13]. Expanded CD8+ T cell clones
were shown to dominate the lesion-infiltrating immune cell
population [10]. However, in these studies only TCR b-chain
rearrangements were analysed, while the matching TCR a-
chains could not be determined.
In both disorders we could identify T-cell clones, characterize
their matching TCR a- and b-chain rearrangements and show
their tissue distribution on the single cell level. Accordingly, our
technology should have wide applications and promote research
into the nature and antigen-specificity of many medically
important protective or pathologic T-cell responses, allowing for
the development of novel diagnostic, therapeutic or preventive
strategies.
Results
Strategy and Primer Design
We established an RT-PCR-based method for the molecular
analysis of the matching i.e. paired ab-TCR rearrangements of
single human T cells. For this purpose we developed nine
degenerate PCR primers (termed Vp1 to Vp9, Table 1), which
cover the entire repertoire of functional TCR b-gene V-elements
and, together with 24 TCR Va-out primers for the Va repertoire
developed recently [2], can simultaneously amplify the cDNA of
all functional human TCR Va- and Vb-region gene transcripts by
multiplex RT-PCR.
The Vb-primers were designed as degenerate primers utilizing
sequence homologies of the various Vb-gene families. To maintain
a high specificity we allowed only one mismatch with the primary
nucleotide Vb-gene sequence. Except Vp1, which is located in the
leader segment, all primers are positioned within the Vb genes.
Primer interactions with the Va-primer set were excluded first by
in silico analysis using several software programs and then
experimentally by testing numerous primer combinations by
RT-PCRs on mRNA from peripheral blood T cells.
The strategy for the molecular characterization of ab-TCR
rearrangements of single T cells is outlined in Figure 1. It starts
with a one step multiplex pre-amplification RT-PCR, where
reverse transcription is done by primers specific for the a- and b-
constant region genes (step 1A). Then the TCR a- and b-chains
are amplified with our novel Vb-gene specific primer set (Table 1)
and the ‘‘outer primer’’ set for the Va-region genes [2] (step 1b).
The pre-amplification PCR products then served as templates to
amplify the b-chains by anchor PCR (step 2) and the a-chains (step
3) by nested PCR.
For anchor PCR we introduced a unique 22-mer oligonucle-
otide as a universal anchor sequence (termed ‘‘UP’’) to the 59 end
of the nine different Vb-gene forward primers (Table 1). The pre-
amplification RT-PCR product was subjected to a run-off PCR
using these nine anchored primers (termed Vp1-UP to Vp9-UP,
Figure 1, step 2A). Next we amplified the respective single cell
TCR b-chain rearrangement independent from the TCR Vb-gene
family using the ‘‘UP’’ anchor primer together with a nested Cb-in
primer in a third PCR (step 2B). When a PCR product for the
TCR b-chain was obtained, we amplified the corresponding TCR
a-chain rearrangement from the pre-amplification multiplex RT-
PCR product in five different nested PCRs (step 3A) using five Va-
in primer pools for the Va repertoire described recently [2]. The
amplified TCR a- and b-chain rearrangements were characterized
by direct sequencing (steps 2C and 3B).
Functional Verification of the Primer Sets
We validated the specificity and compatibility of the 9 Vb-gene
primers and the Cb-out primer in various PCRs together with the
Va primers. Each Vp-primer yielded a PCR product of the
expected size. In Figure 2 we show an experiment where we
reverse transcribed mRNA of peripheral blood T cells with the
Ca-out and Cb-out primers and amplified the transcripts with the
24 Va- and 9 Vb-primers in the pre-amplification multiplex RT-
PCR. We then selectively amplified the rearrangements of the
different Va- and Vb-gene families in a second (Vb) and third (Va)
round of nested PCRs using the nine anchor-forward Vb-primers
with the Cb-in reverse primer, or the 24 Va-in forward primers
with the reverse Ca-in primer [2] in individual reactions. Each Vb-
(Figure 2A, lanes 1–9) and Va-primer (Figure 2B, lane 1–24)
yielded a PCR product of the expected size.
In a second, parallel approach we amplified the pre-amplifica-
tion multiplex RT-PCR product with 23 Vb-primers specific for
the different functional Vb-region gene families together with the
FAM-labelled Cb-in reverse primer [9]. The fragment-lengths
distribution of the hypervariable N(D)N-regions of the PCR
products was then determined by PAGE [14]. All amplified TCR
Vb-gene rearrangements revealed spectratypes with Gaussian-like
distributions typical of polyclonal T-cell populations in peripheral
blood (Figure 2C). Together, these results document that the
combined Va- and Vb-primer sets were capable of simultaneously
amplifying the full functional repertoire of both TCR a- and b-
chains.
Analysis of TCR a- and b-chains of Single T Cells from
Peripheral Blood
We tested the efficiency of this approach for single cell TCR
analysis using CD4+ and CD8+ blood T cells. To maintain an
optimal viability the T cells had been labelled with magnetic beads
and aspirated manually with a pipette in an inverted microscope.
In 82 of 96 CD4+ (85.4%) and in 76 of 96 (79.2%) CD8+ T cells
we could amplify and sequence a functional TCR b-chain
rearrangement. Among these 158 b-chain rearrangements all
functional TCR Vb-gene families were represented except Vb25,
which is rarely rearranged in general. We did not find a single
chain twice, which provides evidence that PCR contaminations
can be excluded. We then characterized the TCR a-chain
rearrangements exemplarily in 20 CD4+ and 20 CD8+ T cells
where we had identified functional b-chains. We obtained the
corresponding TCR a-chains from each individual T cell
investigated. Thus, our technique allows the molecular character-
ization of the paired ab-TCR rearrangements from single viable T
cells with high yields.
When we tested single anti-CD3 labelled T cells from peripheral
blood isolated by flow cytometry, the yield for b-chains in 139
analyzed T cells was 27.3% (38/139), and for matching a-chains
was 39.5% (15/38). The decreased yields are presumably due to
the expected loss and damage of cells during sorting. However,
these data show that our method is also suited for high throughput
screening experiments.
Single Cell TCR Analysis
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TCR Analysis of Single T-cells from the Pathologic
Infiltrate in Psoriasis
Next we examined viable, putatively pathogenic T cells from
explant cell culture from lesional biopsies of five patients with
chronic plaque PV. We divided each biopsy specimen in two parts.
From part ‘‘A’’ we isolated single CD4+ or CD8+ T cells for TCR
analysis. To ensure that T cells with identical b-chains belonged to
a clonally expanded population, we applied two criteria: Firstly,
they had to carry the same Va rearrangement; Secondly, we tested
for select TCR clones whether we could identify the respective b-
chain transcript by PCR and direct DNA sequencing in the second
part ‘‘B’’ of the biopsy.
In patient#1 we analysed 50 CD4+ and in patient #2 50 CD8+
T cells. They had been isolated from ‘‘full thickness’’ biopsies
consisting of dermis and epidermis. In 40/50 CD4+ and 37/50
CD8+ T cells functional ab-TCRs were identified. Three of the 40
CD4+ and two of the 37 CD8+ T cells had identical TCR Vb- and
Va-rearrangements (Table 2). Further, we could amplify their
TCR b-chain transcripts using clone-specific primers from part
‘‘B’’ of the biopsy. According to the above criteria, these T cells
represented clonally expanded populations in the tissue lesion. The
other T cells had unique b-chains.
In patient #3 we analysed both lesional CD4+ and CD8+ T
cells. This patient had been tonsillectomized due to constant PV
flares in association with a recurrent streptococcal angina, which is
the main infectious psoriasis trigger [9,15]. cDNA from blood
lymphocytes and fractions of the tonsils were available for analysis
as well. 100 CD4+ and 50 CD8+ T cells were analyzed. In 82
CD4+ and 41 CD8+ T cells functional ab TCRs were identified.
Two out of the 82 CD4+ T cells had identical ab TCRs. Among
the 41 CD8+ T cells, we found twice two identical ab TCRs and
once three identical ab TCRs (Table 2). The respective b-chain
rearrangements were also identified within the corresponding part
‘‘B’’ of the biopsy, in peripheral blood and/or the tonsillar tissue of
the patient (Table 2). Thus, our technology may identify clonally
expanded ab-T cells in complex T cell populations and track their
distribution across different organs.
Differential Distribution of Psoriatic CD8+ T Clones in
Epidermis and Dermis
While the majority of the psoriatic T-cell infiltrate is located
within the dermis, the development of PV is crucially dependent
on the accumulation of CD8+ T cells within the epidermal
keratinocyte layer [16]. In patients #4 and #5 we therefore
separated dermis and epidermis of the lesional biopsies and
analysed the differential distribution of CD8+ T cells in these
skin compartments. In patient #4 (Table 3) 52 of 60 analyzed
epidermal and 36 of 45 analyzed dermal T cells yielded
functional ab TCRs. We found nine different ab-TCR
rearrangements in duplicates or triplicates among the 52
epidermal CD8+ T cells. Four of these ab-TCR rearrangements
(clones #1, 2, 6, and 9) were also seen in the dermal T cells.
The 36 dermal T cells contained only one TCR clone (#10),
which was not seen in the epidermis. In patient #5 (Table 4),
33 of 40 analyzed epidermal and 25 of 30 analyzed dermal
CD8+ T cells yielded functional ab TCR rearrangements.
Three different ab-TCR rearrangements (clones #1–3) were
selectively present in three, four or seven of the 33 epidermal
CD8+ T cells. Two TCRs (clones #4, 5) were seen in each one
epidermal and dermal T cell. Two other T-cell clones (#6 and
#7) were only seen in the dermis. For select T-cell clones the
Vb signature was also confirmed in part ‘‘B’’ of the biopsy.
Table 1. Sequence, localisation and specificity of oligonucleotide primers.
Primer Vb specificity* Nucleotide sequence Localisation
Vp1 1, 5, 16, 17, 23 59-TSY TTT GTC TCC TGG GAG CA -39 Leader segm.
Vp2 22, 25 59-CCT GAA GTC GCC CAG ACT CC -39 Vb gene
Vp3 18, 24 59-GTC ATS CAG AAC CCA AGA YAC C -39 Vb gene
Vp4 2, 4 59-GGW TAT CTG TMA GMG TGG AAC CTC -39 Vb gene
Vp5 3, 11, 12, 59-ATG TAC TGG TAT CGA CAA GAY C -39 Vb gene
13, 14, 15
Vp6 20 59-CAC TGT GGA AGG AAC ATC AAA CC -39 Vb gene
Vp7 6, 8, 21 59-TCT CCA CTC TSA AGA TCC AGC -39 Vb gene
Vp8 6 59-CAG RAT GTA RAT YTC AGG TGT GAT CC -39 Vb gene
Vp9 7, 9 59-CCA GAC WCC AAR AYA CCT GGT CA -39 Vb gene
UP 59-ACA GCA CGA CTT CCA AGA CTC A -39
Vp2-UP 59-ACA GCA CGA CTT CCA AGA CTC A CCT GAT GTC
GCC CAG ACT CC -39
Vp9-UP 59-ACA GCA CGA CTT CCA AGA CTC A TCA GAC WCC
AAR AYA CCT GGT CA -39
Cb-out Cb 59-TGG TCG GGG AAG AAG CCT GTG -39 Cb gene
Cb -in Cb 59-TCT GAT GGC TCA AAC ACA GC -39 Cb gene
Ca-out Ca 59-GCA GAC AGA CTT GTC ACT GG -39 Cb gene
Ca-in Ca 59 -AG TCT CTC AGC TGG TAC ACG -39 Cb gene
*Arden nomenclature [27]; degenerate primers contain bold letters to indicate nucleotide exchanges. All primers Vp1 to Vp9 were also synthesised with a ‘‘UP’’
sequence at their 59-end (termed Vp1-UP to Vp9-UP). We only show Vp2-UP and Vp9-UP because nucleotides exchanges (underlined) were introduced there to avoid
primer interactions.
doi:10.1371/journal.pone.0037338.t001
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Accordingly, our technology of single cell TCR-analysis may
define the distribution of particular T-cell clones within
heterogeneous T-cell infiltrates. For PV our results indicate
that CD8+ T-cell clones may predominate within the epidermis.
A total of 425 T cells isolated by manual aspiration from the PV
biopsy specimens was analyzed by single cell TCR analysis. The
overall yield was 346 functional ab TCR rearrangements (81.4%).
Direct microscopic analysis of the beads-labelled T cells allowed
an interesting observation. In patient #4 each two CD8+ T cells
from two clones (#2 and #3, Table 3) were seen in tight contact
with target cells of either dendritic (DC) or epithelial-like
morphology (Figure 3A, B). The contacts between the T cells
and antigen presenting cell were so tight that they even survived
the isolation procedure.
TCR Analysis in Cryosections from Brain Lesions of
Multiple Sclerosis
In many conditions only frozen biopsy specimens are available.
Furthermore, it may be of interest to precisely define the
localisation of particular pathogenic T cells in tissue lesions by
immunohistochemistry. Therefore, we tested whether our tech-
nology would be suited to analyze T cells from frozen biopsy
samples using brain tissue sections from a patient with MS. We
stained sections from three different tissue blocks with antibodies
specific for the CD8 beta-chain and the T cell activation marker
CD134 to ensure that we selectively isolated activated effector T
cells, which are more likely to be the mediators of inflammatory
demyelination (Figure 4).
We analysed the TCRs from 643 activated, i.e. double-stained
CD8 beta+/CD134+ single effector T cells isolated by laser
microdissection (Figure 4) from three different tissue blocks of
one big lesion. In 68 of these formerly frozen and then immuno-
stained T cells functional TCR b-chain rearrangements could be
identified (yield: 10.6%) (Table 5, left panel). Of these, four TCR
b-chain rearrangements were detected more than once. We
found a Vb8.1-chain 46 times (clone #8), a Vb6.5-chain 8 times
(clone #6) and a Vb13.1-chain 3 times (clone #10) (Table 6). In
13 of the T cells we could also identify the paired a-chain
(Table 5, right panel, Table 6). Of note, cells of the same T-cell
clones were found not only in different tissue blocks, but were
equally distributed in several morphologically distinct regions of
Figure 1. Strategy to identify paired TCR a- and b-chains from single T cells. Step 1: one step multiplex pre-amplification RT-PCR composed
of step 1A, reverse transcription using a Ca-out and Cb-out primer and step 1B, amplification of the a and b TCR rearrangements by a pool of 9
oligonucleotide Vb primers (Vp1– Vp9) for the Vb repertoire and a pool of 24 oligonucleotide Va primers for the Va repertoire. Subsequently, the PCR
products of the Vb (step 2) and Va (step 3) gene rearrangements are handled separately. Step 2: Introduction of a universal primer (UP) site at the 59-
site of each Vb-rearrangement using primers Vp1-UP to Vp9-UP by a run off reaction (step 2A), followed by amplification of the Vb gene
rearrangement by seminested PCR with the UP primer and a Cb-in primer (step 2B) and sequencing (step 2C). Step 3: Amplification (step 3A) and
sequencing (step 3B) of the Va gene rearrangement by nested PCR from the pre-amplification PCR product using five different nested Va-in primer
pools and a Ca-in primer.
doi:10.1371/journal.pone.0037338.g001
Single Cell TCR Analysis
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37338
the lesion (Table 6). This widespread clonal expansion points to
the processing and presentation of identical or similar antigenic
epitopes by antigen presenting cells in different parts of the brain.
Accordingly, our technology may not only define clonal ab
TCRs in situ but also follow their precise localisation across
pathologic T-cell infiltrates.
Two clones, #10 and #11, had been detected as expanded
clones in earlier studies by other techniques [17,18]. According to
homology searches using the protein query tool of Blast (http://
blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) all other PV
and MS b chains represented unique rearrangements not
identified before.
Identification of T Cells with Dual TCRs
Several expanded clones expressed one b-chain in combination
with two different a-chains. In PV, the T cells of two CD8+ T-cell
clones of patient #3 (Vb6S5 clone, Vb6S3 clone), two CD8+
clones of patient #4 (clones #5, #10) and of the CD8+ clone #1
of patient #5 showed two different functional Va rearrangements
each (Tables 2, 3, 4).
The two strongly expanded MS TCR chains (Vb8.1- and
Vb6.5-chains, MS clones #6 and #8) were each found in
combination with two different a-chain rearrangements as well
(Table 5), however, in different T cells. The Vb6.5-chain of MS
clone 6 was seen either in combination with a Va20S1/Ja30
rearrangement (subclone 6a) or a Va20S1/Ja37 rearrangement
(subclone 6b). The Vb8.1-chain of clone 8 was identified either
with a Va1S5/Ja34 (8a) or Va30S1/Ja18 (8b) rearrangement.
Dual TCRs may have two different specificities. This is of
particular interest, because T cells with dual ab-TCRs have been
implicated in T-cell mediated autoimmunity [19,20].
Discussion
Here we describe a PCR-based technology which to our
knowledge for the first time allows for an unbiased molecular
analysis of matching i.e. paired TCR a- and b-chains from single
human T cells. It employs a set of degenerate Vb-gene primers
and the introduction of an anchor primer site at the 59 end of the
PCR products of Vb-gene rearrangements for further transcript
amplification. Together with previously designed primer sets for
the complete Va repertoire [2] this allows us to characterize
heterodimeric TCRs from single ab T cells. The sensitivity of the
method correlated with the method of isolation and accordingly
mRNA preservation of the single T cells. It reached 80% for
freshly isolated viable T cells aspirated by manual pipetting, but
even pre-stained and laser-dissected T cells from frozen brain
sections yielded an output sufficient to characterize the T cell
infiltrates.
The technology has several obvious advantages. It is indepen-
dent from the availability of monoclonal anti-Vb region antibod-
ies. Neither a prior knowledge of the TCR a- and b-chain regions
nor preceding TCR spectratyping or other methods for the
detection of expanded clones are required. This is documented by
the analysis of the MS lesion: Two of the TCR rearrangements
described here, #10 and #11 (Table 5), had already been
identified formerly by single cell PCR using rearranged genomic
DNA as PCR-template [17] or CDR3 spectratyping of the TCR
b-chain repertoire [18]. In contrast to these earlier studies,
however, we now could also characterize the corresponding a-
chains, and we identified other clonal T cells from the same tissue
blocks, which formerly had escaped detection.
T cell clones prevailed in skin lesions from psoriasis, as well.
Similar to MS [10,18,21,22] this had formerly been proposed from
Figure 2. Functional validation of the primer sets for the simultaneous amplification of the TCR a- and b-gene repertoires by
multiplex RT-PCR. cDNA from PBL was amplified with 24 Va and 9 Vb primers in a multiplex RT-PCR. (A) nine forward Vb-primers (Vp1
to Vp9) were used together with the Cb-out reverse primer (lanes 1–9). (B) 24 Va-out forward primers were used together with the reverse Ca-out
primer (lanes 1–24) in individual reactions (see ref. (2) for a-primer sequences and correlation of the lanes to Va-families). Each Vb- (A) and Va-primer
(B) yielded a PCR product of the expected size. M, molecular weight marker. (C) To validate that all TCR Vb-gene families were covered, the pre-
amplification multiplex RT-PCR product was amplified using 23 Vb-primers specific for the functional Vb-gene repertoire together with the FAM-
labelled Cb-in reverse primer in individual reactions as described [14]. The PCR-products were analyzed by spectratyping their fragment-lengths on a
genetic sequencer.
doi:10.1371/journal.pone.0037338.g002
Single Cell TCR Analysis
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TCR b-chain repertoire studies [6,7,8,9,14]. We could now
document that indeed numerous T cells of the psoriatic T-cell
infiltrate carry identical ab TCRs, and in accordance with the
HLA-Cw6 association of PV [23] this clonality was particular
evident for CD8+ T cells.
Identification of ab-heterodimers by our technology provided
definite evidence that completely identical clones may be present
in morphologically distinct regions of human autoimmune tissue
lesions. In MS considerable numbers of identical T cells were
observed (Table 6). Such pervasive T cell clones [11] are obviously
a quite general phenomenon in MS [10]. In psoriasis, the CD8+ T-
cell clones predominated in the epidermis, indicating that the
epidermis may be the actual site of psoriatic T-cell activation. And
indeed, blocking T cell transmigration from the dermis into the
epidermis by a1b1 integrin antibodies in a human-mouse skin
transplant model may suppress psoriatic inflammation [16].
Identification of the clonal Vb signature in blood and tonsils of
a patient with streptococcal driven psoriasis is in line with our
former observation that the pathogenic T cell clones are not
primary skin-resident T cells but may be recruited from lymphoid
organs such as the tonsils via the blood stream [9].
Thus, our technology facilitates the characterization of complex
T-cell populations and helps to distinguish pathologically relevant
T-cell clones from abundant bystander T cells of inflammatory
infiltrates. It may therefore be used to characterize the distribution
and expansion of particular T-cell clones across tissues or body
fluids. Such T-cell clones may even be identified from low
numbers of cells, where statistical techniques like CDR3
spectratyping [24] are not applicable. In PV less than 40 cells
were sufficient to detect clonal T-cell expansions, as verified by
analysis of an adjacent part of the biopsy.
ab-TCR analysis may help to identify the respective antigen-
presenting events. In PV different T cells with identical TCRs
were seen in direct tight contact with cells of dendritic or epithelial
morphology. So far direct evidence of an antigen-presenting event
in situ, i.e. in the autoimmune tissue lesion, has been rare. The ‘‘in
flagranti’’ observation of a likely antigen-presenting event in a
psoriasis explant (Figure 4) now provides evidence that distinct
antigen-presenting cells in psoriatic lesions may present a
dominant antigen to different T cells of the same clonal origin.
The high sensitivity of our technology is reflected by its ability to
detect dual TCRs on the single cell level. We identified several
CD8+ T-cell clones from skin lesions of the PV patients #3, 4 and
5, which had two different a-chains associated with the same Vb-
chain rearrangement, respectively (Tables 2, 3, 4). Likewise, clones
#6 and #8 from the MS lesion had two different a-chains
associated with a Vb6S5- or Vb8S1-chain (Table 5). In the MS
patient two possibilities are conceivable: Either the antigen-driven
T-cell expansion selected two different T-cell clones each with the
same TCR b-chain but different a-chains, or the T-cell clones
expressed two different Va-chains in a single dual TCR T cell, but
only one a rearrangement was identified due to a low mRNA
preservation. Dual-TCR T cells have been described, and it is
assumed that up to 30% of all T cells may carry dual TCRs [19].
In case of the MS clones, we may not distinguish these possibilities,
because the two a-chains were cloned from different cells with the
same b-chain. However, the psoriasis clones were classical dual
TCR T cells, as the two different a-chains were definitely cloned
from the same T cells. This is the first time that clonal T cells with
dual ab-TCRs were identified directly from human autoimmune
tissue lesions. These T cells likely have two different antigen-
specificities, which may be relevant for the induction of
autoimmunity. In a mouse model of autoimmune encephalitis
employing a dual TCR specific for an exogenous viral antigen and
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myelin basic protein viral infection could brake tolerance to MBP
and induce autoimmune pathology [20] hinting to such a
mechanism in humans as well.
One of the greatest challenges in clinical immunology is the
identification of antigens of T-cell mediated autoimmune disorders
or tumor-specific immune responses. The technical hurdles,
Figure 3. Different antigen presenting cells may present the same antigens to different T cells. Two lesional psoriatic T cells (*) labelled
with CD8 beads are seen in direct contact with dendritic-like cells with antigen presenting cells of dendritic phenotype(c, 200-fold magnification in
an inverted microscope).
doi:10.1371/journal.pone.0037338.g003
Figure 4. Localization of CD8+ T cells infiltrating the MS brain and their isolation by laser microdissection. Cryosections of a frozen
biopsy sample from the MS patient were stained with Cy3-labeled anti-CD8b (red) and Alexa 488-labeled anti-CD134 (green) antibodies. (A–C):
Visualization of activated T cells (white arrows) that are double positive (C) for CD8 (A) and CD134 (B). (D–F): Laser microdissection of T cells stained
for CD8b (red; D) and CD134 (green; E). Activated single cells are dissected at the indicated yellow circles and catapulted out of the tissue directly into
the cap of a PCR tube for subsequent TCR analysis. We show the corresponding bright-light image of the tissue after (F) laser microdissection. The
numbers in the yellow field refer to apparatus parameters (D–F). The scale bars correspond to 20 mm.
doi:10.1371/journal.pone.0037338.g004
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however, are high [1]. The molecular characterization of the
paired ab heterodimers as described here and the identification of
T-cell clones on the single cell level clearly supports that the
immune response in both disorders, PV and MS, is antigen-driven.
Thus, our technology will now allow us to recombinantly
reconstruct functional TCRs from practically any ab-T cell of
choice. Such ‘‘resurrected’’ T cells may then be used to identify the
original antigen-specificity by a most recently developed generally
applicable technology [25] or to test the functional outcome of T-
cell mediated immune reactions in TCR transgenic animals. This
application may significantly promote investigations on T-cell
mediated autoimmune disorders, tumor-specific protective immu-
nity, and infections.
Materials and Methods
Patients
The ethics committee of the medical faculty of the Ludwig-
Maximilian-University of Munich had approved the study.
Patients with type 1 chronic plaque psoriasis (early disease onset,
positive family history for PV and/or presence of HLA-Cw6) [23]
participated voluntarily and gave written informed consent.
Clinical data of the MS patient are described [17,18]. The biopsy
was frozen in liquid nitrogen immediately upon excision.
Isolation of Single T Cells from Peripheral Blood or
Lesional Psoriatic Biopsies
Small spindle shaped biopsies from chronic PV plaques were cut
in half. One part (‘‘A’’) was minced completely mechanically and
cultured for 12 to 24 h in RPMI medium (PAA Laboratories) with
standard supplements to allow T cells to segregate from the tissue
threads. In some experiments, dermis and epidermis were
dissociated by dispase treatment (2.4 U/ml, Roche) for 1 h at
37uC [26] and the T cells isolated from these two different
compartments separately. Part ‘‘B’’ of the biopsy was homoge-
nized in Trizol reagent for the preparation of mRNA and TCR b-
chain cDNA. Peripheral blood lymphocytes (PBL) were prepared
from heparinised venous blood by Ficoll density gradient
centrifugation.
To isolate single CD4+ or CD8+ T cells, explant culture cells or
PBL were suspended in PBS pH 7.2, 2 mM EDTA (auto-
MACSTM Rinsing Solution, Miltenyi Biotec), 0.5% bovine serum
albumin (BSA) and incubated with anti-CD4 or anti-CD8
magnetic beads (Dynabeads, Invitrogen). Beads-coated cell
suspensions were transferred into 6 well microtiter plates (Costar,
Corning) and adjusted to a concentration of 1 to 2 beads-coated T
cells per visual field at 200-fold magnification in an inverted
microscope. Single beads-coated T cells were aspirated in a
volume of ,0.5 ml using a variable 2 ml pipette, transferred into
PCR tubes containing 5.5 ml 1x OneStep RT-PCR buffer
(Qiagen) and stored at 280uC. For FACSorting of single T cells,
PBMC were stained with the anti-CD3 antibody UCHT1 (Dako),
and single cell were sorted into PCR tubes using a FACSVantage
SE cell sorter.
Isolation of Single Cells from Frozen Brain Tissue by Laser
Microdissection
PET membrane slides (P.A.L.M Microlaser) were baked at
180uC for 4 h, UV irradiated and coated with poly-L-lysine
hydrobromide (Sigma). 10 mm thick cryostat sections from frozen
tissue specimens were mounted onto these slides and stored at
280uC. Prior to staining, the slides were thawed, fixed briefly in
100% acetone rehydrated in PBS for 10 seconds, and blocked for 3
minutes in PBS containing 2% BSA (Sigma). Next, the sections
were co-incubated for 5 minutes with an FITC labelled anti
CD134 Antibody (clone ACT35, BD-Pharmingen) and a Cy3
labelled anti-CD8 beta chain antibody (clone 2ST8.547, Beckman
Coulter). The sections were then rinsed with 1 ml of PBS and
incubated for 3 minutes with a 1:100 diluted Alexa-488 labelled
anti-FITC antibody (A11096, Invitrogen) to enhance the fluores-
cence signal.
After a second PBS rinse the sections were covered with 1-
propanol to retard RNase activity and prevent specimen drying.
They were immediately analyzed under a P.A.L.M Microbeam-Z
microscope (Zeiss). Cells that were either double positive for both
T cell markers or single positive for CD8b were marked
electronically using the PalmRobo Software (V3.0, Zeiss). After
evaporation of 1-propanol, the cells were cut and catapulted by
laser pressure into the mineral oil coated lids of single reaction
200 ml PCR tubes.
Primer Design
All functional human TCR b-chain nucleotide sequences from
the IMGT database at http://www.imgt.org/were searched for
regions of nucleotide sequence homology using DNA sequence
analysing software programs including ‘‘Geneious’’ (http://www.
geneious.com); ‘‘CLC workbench’’ (http://www.clcbio.com); and
‘‘FastPCR’’ (http://www.biocenter.helsinki.fi/bi/Programs/
Table 6. Distribution of T cells isolated by laser
microdissection from morphologically distinct regions of the
MS lesion.
b-chains
T cell clone # Block #1 Block #2 Block #3 Total
1 1 1
2 1 1
3 1 1
4 1 1
5 1 1
6 5 3 8
7 1 1
8 23 13 10 46
9 1 1
10 1 2 3
11 1 1
12 1 1 2
13 1 1
Total 36 19 13 68
a-chains
6a 1 1 2
6b 1 1 2
8a 1 1
8b 5 1 1 7
11 1 1
Total 8 3 2 13
We list the numbers of T cells and tissue blocks where TCR b-chains (upper
panel) and a-chains (lower panel) from particular T cell clones were detected.
doi:10.1371/journal.pone.0037338.t006
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fastpcr.htm). Melting temperatures and potential primer-primer
interactions were determined using the IDT oligoanalyzer
software (http://eu.idtdna.com/analyzer/applications/
oligoanalyzer/default.aspx).
We use the TCR nomenclature of Arden et al. [27] throughout.
Reverse Transcription and Pre-amplification of TCR a-
and b-chains by Multiplex PCR
cDNA synthesis was performed directly from single T cells using
the OneStep RT-PCR Kit. 6.5 ml of RT reaction mix with 10 mM
of the Ca-out and Cb-out oligonucleotide primers (Table 1) were
added to the 6.0 ml sample containing the single T cell. Reverse
transcription of TCR mRNA was performed for 35 min at 50uC.
For cells isolated by laser microdissection, 12.5 ml of the RT mix
were added directly into the cap of the reaction tube followed by
centrifugation at 14,000 rpm, 4uC for 3 minutes.
After reverse transcription 12.5 ml PCR mix from the OneStep
RT-PCR Kit were added to the sample. The PCR mix contained
3 mM Va- and Vb-oligonucleotide primers each. The primer set
for the Va-repertoire consisted of the 24 oligonucleotide primers
described recently [2]. The primer set for the Vb repertoire
consisted of 9 oligonucleotide primers (Vp1 to Vp9) given in
Table 1. After an initial incubation for 15 min at 95uC to activate
hot start polymerase, PCR was run for 10 cycles at 94uC for
30 sec, 60uC for 90 sec and 68uC for 60 sec. Then another 30
cycles were run at 94uC for 30 sec, 53uC for 90 sec and 68uC for
60 sec, followed by a final extension at 68uC for 15 min. This pre-
amplification product served as template for the subsequent
characterization of TCR a- and b-chains.
Characterization of the TCR b-chains
To facilitate a further amplification of the TCR b-chains by
PCR, a universal primer (UP)-sequence was added as an anchor
sequence to the 59-end of each Vp1 to Vp9 primer (Vp1-UP to
Vp9-UP). The nucleotide sequences of Vp2-UP and Vp9-UP were
slightly modified to avoid primer interactions (Table 1). 1 ml of the
multiplex PCR product was subjected to a run-off reaction in a
PCR mix composed of 1 ml 10x PCR buffer (Roche), 0.2 ml dNTP
(10 mM each), 7.65 ml H2O, 0.1 ml Vp1-UP to Vp9-UP primers
(11.1 mM each), 0.05 ml Taq DNA Polymerase (5 U/ml, Roche).
The run off conditions were 94uC for 5 min, 53uC for 150 sec,
and 68uC for 15 min.
The TCR b-chain transcripts were then amplified by semi-
nested PCR. 1 ml of the run-off reaction product was used in 20 ml
PCR reaction mix that contained 2.5 mM of the Cb-specific nested
primer (Cb-in) and 2.5 mM of the universal primer (UP) (Roche).
After pre-incubation at 94uC for 2 min, PCR was run for 50 cycles
at 94uC for 30 sec, 58uC for 1 min, 68uC for 1 min. After a final
elongation step at 68uC for 15 min, PCR products were analyzed
by agarose gel electrophoresis and sequenced.
Characterization of the Matching TCR a-chains
Only such cells were tested, which had yielded a PCR product
for the b-chain. The TCR a-chains were amplified by nested PCR
from the pre-amplification product as described [2] with minor
modifications: The concentrations of the Va-in primers were
raised to 1.0 mM, and the Ca-in primers were used at 5 mM.
Further, the touch-down PCR was run with 4 cycles and 1 min
each for the annealing temperatures 61uC, 58uC, and 56uC. Then
40 cycles were run at 53uC. Denaturation and extension steps were
for 30 sec at 95uC and for 1 min at 68uC. PCR products were
analyzed by agarose gel electrophoresis and sequenced.
Analysis of the TCR a- and b-chain Repertoires from
Blood T Cells
The Va- and Vb-TCR repertoires from PBMC were reverse
transcribed and pre-amplified using the multiplex PCR conditions
described above. Individual TCR Va- and Vb-gene families were
then amplified from the multiplex PCR product in separate PCR
reactions and analyzed by agarose gel electrophoresis or by CDR3
fragment lengths spectratyping as described [2,14]. Only the
primers for TRBV8 (59 CCAGCCCTCAGAACCCAG 39),
TRBV21 (59 CTCTCAGGATCCAGCCTGCA 39) and
TRBV25 (59 GATTTTCAGCTAAGTGCCTCC 39) differed
from these protocols, because the original primers for TRBV8
and TRBV21 were located outside the multiplex b-chain PCR
product, and the primer set did not include a primer for the
TRBV25 family.
Detection of Particular TCR Chains by Clone-specific PCR
For select clonal TCR rearrangements detected by single cell
PCR in sample ‘‘A’’ of PV biopsies we investigated by clone-
specific semi-nested RT-PCR whether their particular TCR b-
chain transcripts were also present in cDNA of part ‘‘B’’. The first
PCR employed the respective Vb forward primer and the Cb-out
primer. Then, in a semi-nested PCR, the Vb forward primer and a
CDR3 specific primer, which extended 4 to 6 nucleotides from the
J-region gene into the respective N(D)N-sequence were used. PCR
products were sequenced.
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